Other languages Diaceutics PLC

Equities

Market Closed - London S.E. Other stock markets 11:35:22 2024-04-25 am EDT			5-day change	1st Jan Change
103 ^GBX	0.00%		0.00%	+18.39%

Apr. 02	Roadside shares suspended; Adnams looks for funds	AN
Mar. 21	Diaceutics upgrades diagnositc commercialisation platform, DXRX	AN

Roadside shares suspended; Adnams looks for funds	Apr. 02
Diaceutics upgrades diagnositc commercialisation platform, DXRX	Mar. 21
Diaceutics PLC Launches Significant Upgrade to Its DXRX Platform	Mar. 21
Sondrel wins USD23 million contract	Feb. 27
Diaceutics Expands Lab Network, Data Coverage in Europe	Feb. 27
Diaceutics announces new marketing partnership with KPMG	Feb. 14
Diaceutics maintains "momentum" for year ahead on revenue rise in 2023	Jan. 30
Diaceutics revenue grows but loss widens, CEO Keeling to step down	23-09-26
Diaceutics Announces Executive Changes	23-09-26
Diaceutics CEO to Resign; Chief Innovation Officer Named Successor	23-09-26
Earnings Flash (DXRX.L) DIACEUTICS Posts H1 Revenue GBP9.9M	23-09-26
Diaceutics PLC Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-26
Diaceutics PLC Announces Executive Changes, Effective 1 October 2023	23-09-21
Diaceutics launches daily alerts for DXRX platform	23-08-29
Diaceutics plc Launches Daily Alerts for Dxrx Platform	23-08-29
Diaceutics interim revenue jumps as order book grows to GBP24 million	23-07-25
Diaceutics shares surge on contract win with top US firm	23-06-05
AIM WINNERS & LOSERS: Tristel hails FDA approval of ULT disinfectant	23-06-05
Diaceutics Up 13% Following Three-year Enterprise Contract With Global Pharma Company	23-06-05
Diaceutics PLC Receives USD 10.1 Million Multi-Year Enterprise Engagement with Top 10 Global Pharmaceutical Company	23-06-05

No results for this search